CD4+ T Cell Responses to HLA-DP5-restricted Wild-Type Sequence P53 Peptides in Patients With Head and Neck Cancer
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-009-0661-3
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2009
Authors
Publisher
Springer Science and Business Media LLC